ARVN
Price
$11.94
Change
-$0.26 (-2.13%)
Updated
Jan 15, 11:11 AM (EDT)
Capitalization
783.54M
46 days until earnings call
Intraday BUY SELL Signals
CMPX
Price
$5.88
Change
-$0.16 (-2.65%)
Updated
Jan 15, 11:19 AM (EDT)
Capitalization
1.07B
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ARVN vs CMPX

Header iconARVN vs CMPX Comparison
Open Charts ARVN vs CMPXBanner chart's image
Arvinas
Price$11.94
Change-$0.26 (-2.13%)
Volume$1.5K
Capitalization783.54M
Compass Therapeutics
Price$5.88
Change-$0.16 (-2.65%)
Volume$3.3K
Capitalization1.07B
ARVN vs CMPX Comparison Chart in %
View a ticker or compare two or three
VS
ARVN vs. CMPX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and CMPX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (ARVN: $12.20 vs. CMPX: $6.04)
Brand notoriety: ARVN and CMPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 115% vs. CMPX: 293%
Market capitalization -- ARVN: $783.54M vs. CMPX: $1.07B
ARVN [@Biotechnology] is valued at $783.54M. CMPX’s [@Biotechnology] market capitalization is $1.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 1 FA rating(s) are green whileCMPX’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 1 green, 4 red.
  • CMPX’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than CMPX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 4 TA indicator(s) are bullish while CMPX’s TA Score has 3 bullish TA indicator(s).

  • ARVN’s TA Score: 4 bullish, 3 bearish.
  • CMPX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ARVN is a better buy in the short-term than CMPX.

Price Growth

ARVN (@Biotechnology) experienced а -1.69% price change this week, while CMPX (@Biotechnology) price change was +10.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

ARVN is expected to report earnings on Mar 02, 2026.

CMPX is expected to report earnings on Feb 27, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CMPX($1.07B) has a higher market cap than ARVN($784M). CMPX YTD gains are higher at: 12.477 vs. ARVN (2.867). CMPX has higher annual earnings (EBITDA): -69.96M vs. ARVN (-96.5M). ARVN has more cash in the bank: 788M vs. CMPX (220M). ARVN has less debt than CMPX: ARVN (9.3M) vs CMPX (9.87M). ARVN has higher revenues than CMPX: ARVN (312M) vs CMPX (0).
ARVNCMPXARVN / CMPX
Capitalization784M1.07B73%
EBITDA-96.5M-69.96M138%
Gain YTD2.86712.47723%
P/E RatioN/AN/A-
Revenue312M0-
Total Cash788M220M358%
Total Debt9.3M9.87M94%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
56
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNCMPX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
74%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 1 day ago
89%
Declines
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ARVN
Daily Signal:
Gain/Loss:
CMPX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYEAX243.384.65
+1.95%
Rydex Energy H
TADFX8.96N/A
N/A
Transamerica Sustainable Equity Inc R6
SCSAX17.61-0.02
-0.11%
Allspring Common Stock A
WASAX23.12-0.03
-0.13%
Nomura Asset Strategy Fund Cl A
ISTIX87.69-1.20
-1.35%
Nomura Science and Technology I

ARVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARVN has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ARVN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARVN
1D Price
Change %
ARVN100%
-0.73%
AXON - ARVN
46%
Loosely correlated
-1.92%
VCYT - ARVN
46%
Loosely correlated
-1.39%
ERAS - ARVN
40%
Loosely correlated
+10.73%
ATXS - ARVN
40%
Loosely correlated
+0.24%
SRPT - ARVN
40%
Loosely correlated
+6.24%
More

CMPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMPX has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CMPX jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMPX
1D Price
Change %
CMPX100%
+8.24%
VCYT - CMPX
37%
Loosely correlated
-1.39%
ORIC - CMPX
35%
Loosely correlated
+10.95%
ARVN - CMPX
33%
Loosely correlated
-0.73%
EWTX - CMPX
32%
Poorly correlated
+12.91%
INSM - CMPX
32%
Poorly correlated
-0.16%
More